SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001104659-18-023165
Filing Date
2018-04-10
Accepted
2018-04-10 08:31:05
Documents
3

Document Format Files

Seq Description Document Type Size
1 425 a18-9862_2425.htm 425 28002
2 GRAPHIC g98622bgi001.gif GRAPHIC 3221
3 GRAPHIC g98622bgi002.gif GRAPHIC 3283
  Complete submission text file 0001104659-18-023165.txt   38914
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filed by) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Subject) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 000-23186 | Film No.: 18746880
SIC: 2836 Biological Products, (No Diagnostic Substances)